4.7 Article

Nucleoside-modified AdoMet analogues for differential methyltransferase targeting

Journal

CHEMICAL COMMUNICATIONS
Volume 56, Issue 14, Pages 2115-2118

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c9cc07807j

Keywords

-

Funding

  1. ERC [772280]
  2. DFG [SFB858, IRTG 2027]
  3. NIAID, NIH [HHSN272201700059C]
  4. HHS [HHSN272201700059C]
  5. European Research Council (ERC) [772280] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Methyltransferases (MTases) modify a wide range of biomolecules using S-adenosyl-l-methionine (AdoMet) as the cosubstrate. Synthetic AdoMet analogues are powerful tools to site-specifically introduce a variety of functional groups and exhibit potential to be converted only by distinct MTases. Extending the size of the substituent at the sulfur/selenium atom provides selectivity among MTases but is insufficient to discriminate between promiscuous MTases. We present a panel of AdoMet analogues differing in the nucleoside moiety (NM-AdoMets). These NM-AdoMets were efficiently produced by a previously uncharacterized methionine adenosyltransferase (MAT) from methionine and ATP analogues, such as ITP and N-6-propargyl-ATP. The N-6-modification changed the relative activity of three representative MTases up to 13-fold resulting in discrimination of substrates for the methyl transfer and could also be combined with transfer of allyl and propargyl groups.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available